Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Estelle Duprez

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Critical Reviews in Oncology/Hematology|July 11, 2013
Epigenetics in focus: pathogenesis of myelodysplastic syndromes and the role of hypomethylating agentsValeria Santini, Ari Melnick, Jaroslaw P Maciejewski, et al.
Epigenetics & Chromatin|May 7, 2026
H1.3 depletion in AML cells prompts H1.2 redistribution, chromatin remodeling and cell cycle defectsClara Tellez-Quijorna, Lia N'Guyen, Núria Serna-Pujol, et al.
Nucleic Acids Research|March 21, 2019
PLZF limits enhancer activity during hematopoietic progenitor agingMathilde Poplineau, Julien Vernerey, Nadine Platet, et al.
Blood|March 5, 2016
PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progressionChristelle Vincent-Fabert, Nadine Platet, Amelle Vandevelde, et al.
Genes & Development|May 20, 2009
The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformationHanane Boukarabila, Andrew J Saurin, Eric Batsché, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
TP53INP1 deficiency maintains murine B lymphopoiesis in aged bone marrow through redox-controlled IL-7R/STAT5 signalingBochra Zidi, Christelle Vincent-Fabert, Laurent Pouyet, et al.
Cell|July 28, 2009
MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cellsSandrine Sarrazin, Noushine Mossadegh-Keller, Taro Fukao, et al.
Nucleic Acids Research|February 10, 2018
Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activityMyriam Koubi, Mathilde Poplineau, Julien Vernerey, et al.
Leukemia & Lymphoma|February 8, 2024
Long-term survival of <i>NPM1</i> AML treated with intensive chemotherapy with extensive molecular data availableSylvain Garciaz, Guillaume Berton, Marie-Anne Hospital, et al.
Plos One|September 28, 2011
Characterisation of genome-wide PLZF/RARA target genesSalvatore Spicuglia, Christelle Vincent-Fabert, Touati Benoukraf, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Critical Reviews in Oncology/Hematology|July 11, 2013
Epigenetics in focus: pathogenesis of myelodysplastic syndromes and the role of hypomethylating agentsValeria Santini, Ari Melnick, Jaroslaw P Maciejewski, et al.
Epigenetics & Chromatin|May 7, 2026
H1.3 depletion in AML cells prompts H1.2 redistribution, chromatin remodeling and cell cycle defectsClara Tellez-Quijorna, Lia N'Guyen, Núria Serna-Pujol, et al.
Nucleic Acids Research|March 21, 2019
PLZF limits enhancer activity during hematopoietic progenitor agingMathilde Poplineau, Julien Vernerey, Nadine Platet, et al.
Blood|March 5, 2016
PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progressionChristelle Vincent-Fabert, Nadine Platet, Amelle Vandevelde, et al.
Genes & Development|May 20, 2009
The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformationHanane Boukarabila, Andrew J Saurin, Eric Batsché, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
TP53INP1 deficiency maintains murine B lymphopoiesis in aged bone marrow through redox-controlled IL-7R/STAT5 signalingBochra Zidi, Christelle Vincent-Fabert, Laurent Pouyet, et al.
Cell|July 28, 2009
MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cellsSandrine Sarrazin, Noushine Mossadegh-Keller, Taro Fukao, et al.
Nucleic Acids Research|February 10, 2018
Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activityMyriam Koubi, Mathilde Poplineau, Julien Vernerey, et al.
Leukemia & Lymphoma|February 8, 2024
Long-term survival of <i>NPM1</i> AML treated with intensive chemotherapy with extensive molecular data availableSylvain Garciaz, Guillaume Berton, Marie-Anne Hospital, et al.
Plos One|September 28, 2011
Characterisation of genome-wide PLZF/RARA target genesSalvatore Spicuglia, Christelle Vincent-Fabert, Touati Benoukraf, et al.
Pageof 3